---
figid: PMC5335622__fcell-05-00016-g0002
figlink: /pmc/articles/PMC5335622/figure/F2/
number: F2
caption: 'Theoretical concept of combined application of checkpoint blockade therapy
  and DGK-inhibition. (A) Functional unresponsiveness of TILs in the tumor milieu
  may have different mutually non-exclusive causes: (i) Ligation of PD-1 on T cells
  by tumor expressed PD-L1 may cause recruitment of phosphatase SHP2 and subsequent
  dephosphorylation of the TCR proximal signal transmitter Lck as well as attenuation
  of AKT-signaling. Consequently, signals initiated by TCR-peptide/MHC recognition
  intended to activate T-cell effector function (degranulation leading to lysis of
  target cells as well as IFNγ) are interrupted. The signal interruption through PD-1/PD-L1
  classically occurs as a consequence of T-cell exhaustion. (ii) Anergy is another
  mechanism of T-cell silencing. The underlying cause is upregulated diacylglycerol
  kinase (DGK), in T cells mainly DGK-α and DGK-ζ. DGKs metabolize diacylglycerol
  (DAG) to phosphatidic acid (PA) lowering DAG levels which are necessary to activate
  TCR distal signaling through Ras/ERK. The ERK pathway is critically import for the
  degranulation process that delivers lytic proteins into the target cell for target
  cell death. (B) De-blocking the exhaustion pathway through checkpoint antibodies
  (anti-PD-1/PD-L1) releases the proximal brake at the TCR-associated molecules (Lck-
  and AKT-phosphorylation); however, distal brakes through DGK may still be active
  (blocked ERK pathway and attenuated PKC- and NFκB-activation) preventing full activation
  of the T cell‘s antitumor functions (degranulation, IFNγ). (C) Combined treatment
  with checkpoint antibodies and DGK-inhibitor may be required to open the signaling
  cascade fully, allowing effector function.'
pmcid: PMC5335622
papertitle: 'DGK-α: A Checkpoint in Cancer-Mediated Immuno-Inhibition and Target for
  Immunotherapy.'
reftext: Elfriede Noessner. Front Cell Dev Biol. 2017;5:16.
pmc_ranked_result_index: '145061'
pathway_score: 0.9396897
filename: fcell-05-00016-g0002.jpg
figtitle: Theoretical concept of combined application of checkpoint blockade therapy
  and DGK-inhibition
year: '2017'
organisms:
- Homo sapiens
ndex: a5bcefee-df03-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5335622__fcell-05-00016-g0002.html
  '@type': Dataset
  description: 'Theoretical concept of combined application of checkpoint blockade
    therapy and DGK-inhibition. (A) Functional unresponsiveness of TILs in the tumor
    milieu may have different mutually non-exclusive causes: (i) Ligation of PD-1
    on T cells by tumor expressed PD-L1 may cause recruitment of phosphatase SHP2
    and subsequent dephosphorylation of the TCR proximal signal transmitter Lck as
    well as attenuation of AKT-signaling. Consequently, signals initiated by TCR-peptide/MHC
    recognition intended to activate T-cell effector function (degranulation leading
    to lysis of target cells as well as IFNγ) are interrupted. The signal interruption
    through PD-1/PD-L1 classically occurs as a consequence of T-cell exhaustion. (ii)
    Anergy is another mechanism of T-cell silencing. The underlying cause is upregulated
    diacylglycerol kinase (DGK), in T cells mainly DGK-α and DGK-ζ. DGKs metabolize
    diacylglycerol (DAG) to phosphatidic acid (PA) lowering DAG levels which are necessary
    to activate TCR distal signaling through Ras/ERK. The ERK pathway is critically
    import for the degranulation process that delivers lytic proteins into the target
    cell for target cell death. (B) De-blocking the exhaustion pathway through checkpoint
    antibodies (anti-PD-1/PD-L1) releases the proximal brake at the TCR-associated
    molecules (Lck- and AKT-phosphorylation); however, distal brakes through DGK may
    still be active (blocked ERK pathway and attenuated PKC- and NFκB-activation)
    preventing full activation of the T cell‘s antitumor functions (degranulation,
    IFNγ). (C) Combined treatment with checkpoint antibodies and DGK-inhibitor may
    be required to open the signaling cascade fully, allowing effector function.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - PIK3R3
  - CHUK
  - PLCG1
  - IFNG
  - PIK3CG
  - DGKD
  - MAPK3
  - PIK3CB
  - NFATC3
  - NFATC4
  - DGKI
  - NFATC2
  - DGKZ
  - DGKE
  - AKT2
  - AKT1
  - CD28
  - PLCG2
  - NFAT5
  - NFATC1
  - NRAS
  - AKT3
  - HRAS
  - KRAS
  - PIK3CA
  - FOSL1
  - JUNB
  - FOS
  - FOSB
  - NFKB1
  - PDCD1
  - CD3D
  - CD3E
  - JUND
  - ZAP70
  - FOSL2
  - PIK3R4
  - LCK
  - CD3G
  - DGKH
  - IKBKG
  - JUN
  - PIK3R6
  - CD247
  - CD274
  - DGKB
  - PIK3CD
  - PIK3R5
  - IKBKB
  - PTPN11
  - DGKA
  - TRD
  - TRG
  - DGKG
  - DGKK
  - DGKQ
  - TRA
  - TRB
  - Cancer
genes:
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: IFNY
  symbol: IFNG
  source: hgnc_symbol
  hgnc_symbol: IFNG
  entrez: '3458'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKD
  entrez: '8527'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC3
  entrez: '4775'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC4
  entrez: '4776'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKI
  entrez: '9162'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKZ
  entrez: '8525'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKE
  entrez: '8526'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: CD28
  symbol: CD28
  source: hgnc_symbol
  hgnc_symbol: CD28
  entrez: '940'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFAT5
  entrez: '10725'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PD-1/PD-L1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: cD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3D
  entrez: '915'
- word: cD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3E
  entrez: '916'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: ZAP70
  symbol: ZAP70
  source: hgnc_symbol
  hgnc_symbol: ZAP70
  entrez: '7535'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Lck
  symbol: LCK
  source: hgnc_symbol
  hgnc_symbol: LCK
  entrez: '3932'
- word: cD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3G
  entrez: '917'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKH
  entrez: '160851'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: cD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD247
  entrez: '919'
- word: PD-1/PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKB
  entrez: '1607'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: SHP2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKA
  entrez: '1606'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKG
  entrez: '1608'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKK
  entrez: '139189'
- word: DGK
  symbol: DGK
  source: bioentities_symbol
  hgnc_symbol: DGKQ
  entrez: '1609'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC5335622__F2
redirect_from: /figures/PMC5335622__F2
figtype: Figure
---
